[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]

[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]

OBJECTIVE: A cost-per-responder model was developed to compare the pharmacoeconomic value of dupilumab and tralokinumab, in combination with topical corticosteroids (TCS), for treating atopic dermatitis (AD) in Italy. METHODS: An indirect treatment comparison (ITC) was conducted using placebo arms f...

Full description

Saved in:
Bibliographic Details
Main Authors: Paolo Gisondi, Andrea Chiricozzi, Marcello Pani, Massimiliano Povero, Luca Castello, Maria Paola Pedone, Kerry Noonan, Zhixiao Wang, Roberta Di Turi
Format: Article
Language:English
Published: SEEd Medical Publishers 2025-05-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
cost per responder
atopic dermatitis
dupilumab
tralokinumab
number needed to treat
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1571
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items